← Back to Screener
Seer, Inc. Class A Common Stock (SEER)
Price$1.99
Favorite Metrics
Price vs S&P 500 (26W)-18.25%
Price vs S&P 500 (4W)9.55%
Market Capitalization$112.84M
All Metrics
Book Value / Share (Quarterly)$4.61
P/TBV (Annual)0.24x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.29%
Cash Flow / Share (Quarterly)$-0.82
Price vs S&P 500 (YTD)5.15%
Gross Margin (TTM)50.72%
Net Profit Margin (TTM)-432.47%
EPS (TTM)$-1.28
10-Day Avg Trading Volume0.61M
EPS Excl Extra (TTM)$-1.28
Revenue Growth (5Y)90.55%
EPS (Annual)$-1.28
ROI (Annual)-28.38%
Gross Margin (Annual)51.06%
Net Profit Margin (5Y Avg)-649.64%
Cash / Share (Quarterly)$3.31
Revenue Growth QoQ (YoY)5.02%
ROA (Last FY)-24.86%
Revenue Growth TTM (YoY)-11.59%
EBITD / Share (TTM)$-1.27
ROE (5Y Avg)-22.30%
Operating Margin (TTM)-458.71%
Cash Flow / Share (Annual)$-0.82
P/B Ratio0.44x
P/B Ratio (Quarterly)0.39x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)5.23x
ROA (TTM)-23.10%
EPS Incl Extra (Annual)$-1.28
Current Ratio (Annual)12.84x
Quick Ratio (Quarterly)12.23x
3-Month Avg Trading Volume0.29M
52-Week Price Return1.01%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.34
P/S Ratio (Annual)6.81x
Asset Turnover (Annual)0.06x
52-Week High$2.41
Operating Margin (5Y Avg)-701.05%
EPS Excl Extra (Annual)$-1.28
CapEx CAGR (5Y)-16.88%
26-Week Price Return-9.50%
Quick Ratio (Annual)12.23x
13-Week Price Return4.17%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)12.84x
Enterprise Value$65.557
Revenue / Share Growth (5Y)91.86%
Asset Turnover (TTM)0.04x
Book Value / Share Growth (5Y)-8.72%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.07x
Pretax Margin (Annual)-442.75%
Cash / Share (Annual)$3.31
3-Month Return Std Dev56.37%
Gross Margin (5Y Avg)49.84%
Net Income / Employee (TTM)$-1
ROE (Last FY)-28.38%
EPS Basic Excl Extra (Annual)$-1.28
Receivables Turnover (TTM)2.38x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.28
Receivables Turnover (Annual)2.78x
ROI (TTM)-26.04%
P/S Ratio (TTM)9.01x
Pretax Margin (5Y Avg)-649.26%
Revenue / Share (Annual)$0.29
Tangible BV / Share (Annual)$7.05
Price vs S&P 500 (52W)-34.08%
Year-to-Date Return9.29%
5-Day Price Return4.17%
EPS Normalized (Annual)$-1.28
ROA (5Y Avg)-20.10%
Net Profit Margin (Annual)-443.96%
Month-to-Date Return19.05%
Cash Flow / Share (TTM)$-1.35
EBITD / Share (Annual)$-1.27
Operating Margin (Annual)-470.45%
ROI (5Y Avg)-22.30%
EPS Basic Excl Extra (TTM)$-1.28
P/TBV (Quarterly)0.27x
P/B Ratio (Annual)0.39x
Inventory Turnover (TTM)1.07x
Pretax Margin (TTM)-431.25%
Book Value / Share (Annual)$4.61
Price vs S&P 500 (13W)1.30%
Beta1.65x
Revenue / Share (TTM)$0.22
ROE (TTM)-26.04%
52-Week Low$1.65
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SEERSeer, Inc. Class A Common Stock | 9.01x | 90.55% | 50.72% | -458.71% | $1.99 |
AAgilent Technologies Inc. | 4.83x | 5.41% | 52.60% | 20.40% | $120.96 |
WATWaters Corp | 10.18x | 6.00% | 59.28% | 25.36% | $335.61 |
MTDMettler-Toledo International | 6.66x | 5.47% | 59.37% | 26.05% | $1324.66 |
ILMNIllumina Inc | 4.69x | 6.04% | 66.61% | 18.44% | $132.86 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $93.03 |
BIOBio-Rad Laboratories, Inc.Class A | 3.17x | 0.29% | 52.01% | 1.59% | $303.34 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.17x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRBruker Corporation | 1.81x | 11.57% | 47.13% | 1.40% | $41.10 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.81x | 11.57% | 47.13% | 1.40% | $320.13 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.50 |
About
Seer Inc provides proteomics solutions for researchers using proprietary engineered nanoparticle technology. Its Proteograph Product Suite enables rapid, unbiased analysis of the complete protein profile (proteome) in biological samples at scale. This addresses a key need in life science research by delivering comprehensive protein analysis capabilities.